Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19

J.J. Swen, T. van der Straaten, J.A.M. Wessels, M.L. Bouvy, E.E.W. Vlassak, W.J.J. Assendelft, H.J. Guchelaar

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	363-370
Number of pages	8
Journal	European Journal of Clinical Pharmacology
Volume	68
Issue number	4
Publication status	Published - 2012

Cite this

@article{53a0cdbef9d04f828962430c7cd0fe2b,

title = "Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19",

author = "J.J. Swen and {van der Straaten}, T. and J.A.M. Wessels and M.L. Bouvy and E.E.W. Vlassak and W.J.J. Assendelft and H.J. Guchelaar",

year = "2012",

language = "English",

volume = "68",

pages = "363--370",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

publisher = "Springer",

number = "4",

}

TY - JOUR

T1 - Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19

AU - Swen, J.J.

AU - van der Straaten, T.

AU - Wessels, J.A.M.

AU - Bouvy, M.L.

AU - Vlassak, E.E.W.

AU - Assendelft, W.J.J.

AU - Guchelaar, H.J.

PY - 2012

Y1 - 2012

M3 - Article

SN - 0031-6970

VL - 68

SP - 363

EP - 370

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

IS - 4

ER -